Possible catalyst for the cannabis industry in September
September is starting to be interesting for the better marijuana stocks to buy now. In Congress, a recent amendment to a defense bill could result in federal reform of cannabis banking for the U.S. market. In the detail Rep, Ed Perlmutter is trying to attach the amendment which is almost identical to the SAFE Banking Act. This amendment is attached to a defense bill that would give him a much better chance of making it through the Senate.
Marijuanastocks.com – MarijuanaStocks
For the cannabis industry, this could be a huge change in momentum that creates more growth across the United States. With the ability to do regular banking and get capital from banks, we could see rapid growth in the US market. As new markets are introduced in places like New York and New Jersey, the cannabis market continues to expand in the United States. In Michigan, adult sales increased 112% year-over-year to $ 125.5 million.
In the United States, many cannabis companies have reported significant revenue growth for the first half of 2021. This should continue judging by the indications many of these companies give in their outlook. Unfortunately for investors, this did not translate into market gains. Instead, for more than six months, the cannabis industry has seen a sharp decline. But current trading levels could be a good opportunity for investors to find best cannabis stocks at lower levels.
The best cannabis stocks right now and the best US stocks in jars
Now, after several months of consolidation, there could be a catalyst in the works for the cannabis industry. For investors, it is important to research cannabis companies before taking a job. Tracking a stock’s performance in the market and reviewing the financial results can help you assess the best potted stocks to invest in. If the February highs are a measure of the values the cannabis industry could achieve with federal cannabis reform, then those could be decent. entry levels currently.
Overall, some of these cannabis companies are showing significant growth and expanding rapidly in the United States. For investors looking to invest in the US cannabis market, there are many successful companies in the industry. As we continue into the fourth quarter, these pot stocks could see some upside. Let’s look at 3 of the best cannabis stocks to invest in for September.
Best stock of marijuana in the United States in September 2021
- Trulieve Cannabis Corp. (OTC: TCNNF)
- Ayr Well-being Inc. (OTC: AYRWF)
- Columbia Care Inc. (OTC: CCHWF)
Trulieve Cannabis Corp.
Currently, Trulieve Cannabis Corp. holds the largest market share in Florida with over 50% of legal cannabis sales in the state. Additionally, the company is a leading and most successful cannabis company in the process of acquiring Harvest Health & Recreation Inc. (OTC: HRVSF). When completed, the new company will have consensus 2021 revenue of more than $ 1.2 billion. Currently, the company has 88 stores in Florida and 97 nationwide, growing strategically in new markets. Additionally, this month the company announced the launch of a brand portfolio that includes four brand models designed to meet the needs of new cannabis consumers and connoisseurs.
September 13e Trulieve has launched a new range of concentrates using hydrocarbon extracts. Specifically, hydrocarbon extracts provide patients with high quality full spectrum concentrates as a particularly potent, aromatic and high purity drug. In July, Trulieve announced that it had received production license approval in Georgia, giving it an additional presence in the Southeast cannabis market. Notably, the company also opened its first dispensary in the state of Massachusetts, adding another market in which it can generate growth. In August, Trulieve released its financial results for the second quarter of 2021 with a record performance. As a result, the company reached its 14e consecutive quarter of profitability has served more than 500,000 cannabis customers. In detail, the company reported revenues of $ 215.1 million and generated net income of $ 40.9 million.
Ayr Well-being Inc.
Next on the list is Ayr Wellness Inc., the fourth largest cannabis company in the cannabis market in Florida. At present, Ayr has 38 operating dispensaries in Florida and a total of 52 stores nationwide. Additionally, the company entered the Illinois market with the acquisition of Herbal Remedies Dispensaries, LLC. In addition, Ayr was given a provisional license to sell cannabis for adult use at dispensaries in Greater Boston, Massachusetts. Specifically, Ayr has also agreed to acquire Tahoe Hydro, an award-winning grower and high-quality cannabis flower product in Nevada. In addition, Ayr Wellness Partner Land of Lincoln has obtained a retail dispensary license in Illinois through the state lottery process.
In September, the company signed an agreement to acquire the owner of the cannabis-infused hard salts Levia. In August, Ayr released its second quarter 2021 results with revenue of $ 91.3 million, up 222% year-over-year. The company has adjusted EBITDA of $ 27.4 million based on US GAAP, up 225% year-over-year. Ayr incurred a US GAAP operating loss of $ 24.9 million, which included one-time expenses and non-operating adjustments of $ 52.3 million. The company raised its 2022 revenue target to $ 800 million with an AEBITDA of $ 300 million. In addition, Ayr provided a revenue forecast of $ 100 million for the third quarter of 2021.
Columbia Care Inc.
Columbia Care Inc. which is able to grow rapidly once legalization is completed in New York State. In 2021, the acquisition of a 34-acre grow site on Long Island gave the company one of the largest cannabis footprints to serve the East Coast market. Currently, Columbia Care operates in 18 US markets and operates 130 facilities, including 99 dispensaries and 31 growing and manufacturing facilities. In July, the company announced the launch of operations in the West Virginia market. Columbia Care plans to begin cultivation in the state at its factory in Falling Waters.
Notably, the company released its second quarter 2021 results with record quarterly revenue of $ 109.7 million, up 232% year-over-year. Columbia Care posted record quarterly adjusted gross profit of $ 47.7 million, a 300% year-over-year increase. Specifically, the company has a record Adjusted EBITDA of $ 16.4 million, up $ 21.1 million year over year. Recently, the company completed the acquisition of Green Leaf Medical, establishing a leading market position in the mid-Atlantic. Columbia Care has appointed Phillip Goldberg of Green Leaf Medical to its board of directors. In September, the company received state approval to rename its business footprint across all of its 14 locations in Florida. Additionally, Columbia Care is celebrating the start of sales of whole-flower cannabis in Virginia.